Is Max Healthcare Institute (MAXHEALTH) overvalued or fairly valued?

MarketChacha shows Max Healthcare Institute's valuation in context — a forward P/E of about 45.4, a price-to-book of about 10.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Max Healthcare Institute's revenue?

Max Healthcare Institute reported revenue of ₹8,373 Cr for FY2026, with net profit of ₹1,442 Cr, per official filings.

What is the share price of Max Healthcare Institute (MAXHEALTH)?

Max Healthcare Institute last traded at ₹1,085.60 (-0.4% on the day), as of 7/21/2026 — a delayed quote shown for education, not investment advice.

Max Healthcare Institute

MAXHEALTH · NSE · Healthcare · India

₹1,085.60-0.4%

Delayed · as reported by Yahoo Finance · as of Jul 21, 2026, 5:38 AM

Snapshot

TickerMAXHEALTH

ExchangeNSE

SectorHealthcare

IndustryMedical Care Facilities

CountryIndia

HeadquartersGurugram, India

Market cap₹1,07,290 Cr

P/B10.0

Volume3.6L

Websitewww.maxhealthcare.in

Filings tracked0

About Max Healthcare Institute

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, Internal Medicine, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic testing services to patients. In addition, it provides organ and tissue donation, preventive health checks, ambulance services, immigration services, air ambulance, and insurance and TPA services. The company operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Profile as reported by Yahoo Finance.

Who owns it

Promoters27.1%
Institutions58.9%
Public & other13.9%

265 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 7.0 points over the period — profitability is trending down.

Net margin trend24.2% → 17.2%

Margin has compressed by about 7.0 points over the period — profitability is trending down.

Growth qualityrev 22% · PAT 9%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹2,927 Cr · EPS 4.48

Est. earnings growth -10.8%

Next fiscal year

Rev ₹13,958 Cr · EPS 24.28

Est. earnings growth +24.0%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹903.0052-wk range₹1,301.70

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹1,07,290 Cr

Day change

-0.4%

Fwd P/E

45.4

P/B

10.0

Div yield

0.18%

Beta

0.08

Revenue (FY2026)

₹8,373 Cr

Net margin

17.2%

Revenue CAGR (3y)

+22.4%

Profit CAGR (3y)

+9.3%

Net profit (FY2026)

₹1,442 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about MAXHEALTH

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹8,373 Cr	₹1,442 Cr	17.2%
FY2025	₹7,028 Cr	₹1,076 Cr	15.3%
FY2024	₹5,406 Cr	₹1,058 Cr	19.6%
FY2023	₹4,563 Cr	₹1,104 Cr	24.2%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹2,143 Cr	₹342 Cr	16.0%
2025Q4	₹2,068 Cr	₹301 Cr	14.6%
2025Q3	₹2,135 Cr	₹491 Cr	23.0%
2025Q2	₹2,028 Cr	₹308 Cr	15.2%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.